Axsome Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AXSM Nasdaq 2830 www.axsome.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Axsome Therapeutics, Inc.

Shopify downgraded, Five Below upgraded: Wall Street's top analyst calls - Jul 21st, 2026 7:40 am
Jazz Pharmaceuticals (JAZZ) Refocuses Its Sleep Franchise, Is The Stock Still Cheap? - Jul 18th, 2026 1:11 am
Axsome's NDA for AXS-12 in Narcolepsy Gets FDA Acceptance - Jul 16th, 2026 9:58 am
Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-12 for the Treatment of Cataplexy in Narcolepsy - Jul 15th, 2026 5:00 am
Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10 - Jul 14th, 2026 5:00 am
3 Under-the-Radar Stocks to Buy and Hold - Jul 10th, 2026 12:50 pm
Axsome Therapeutics (AXSM) Stock Looks Pricey On Sales Yet Fair On Value - Jul 9th, 2026 8:11 pm
How Investors May Respond To Axsome Therapeutics (AXSM) Advancing Solriamfetol Into Phase 3 Pediatric ADHD Trials - Jul 9th, 2026 3:14 pm
Axsome Therapeutics (AXSM) Following FOCUS 2 Dosing Is The ADHD Upside Already Priced In - Jul 9th, 2026 2:14 pm
Dow Jones Futures: Nasdaq Eyes Key Levels Amid Iran News; Nvidia, Valero, Dell, SpaceX In Focus - Jul 9th, 2026 6:09 am
Better Growth Buy: Axsome vs Revolution Medicines - Jul 9th, 2026 2:15 am
Is Axsome Therapeutics, Inc. (AXSM) Among the Best Under-the-Radar Stocks to Invest In? - Jul 8th, 2026 1:20 pm
Axsome Begins Phase III Study on Solriamfetol for ADHD in Children - Jul 8th, 2026 9:19 am
Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder (ADHD) - Jul 7th, 2026 5:00 am
Is Axsome Therapeutics Stock a Millionaire Maker? Here's What the Numbers Say. - Jul 2nd, 2026 6:25 am
TARS Stock Drops After Culper Research Accuses Tarsus Of Illegal Medicare Copay Scheme - Jul 1st, 2026 1:28 pm
Harmony Biosciences Stock Outlook as Wakix Growth Meets Pipeline - Jun 29th, 2026 11:40 am
Axsome Therapeutics Initiates FOCUS-3 Phase 3 Trial of Solriamfetol in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) - Jun 26th, 2026 5:00 am
Axsome Therapeutics Highlights the Importance of Brain Health During Alzheimer's & Brain Awareness Month - Jun 18th, 2026 5:00 am
3 Under-the-Radar Stocks to Buy and Hold for a Decade - Jun 16th, 2026 1:50 am